P53 is the strongest predictor of survival in high-risk primary breast cancer patients undergoing high-dose chemotherapy with autologous blood stem cell support

The antiemetic efficacy of granisetron plus dexamethasone, haloperidol and loracepam in breast cancer patients treated with high-dose chemotherapy with peripheral blood stem-cell support

Supportive Care in Cancer ◽

10.1007/s005200050168 ◽

1998 ◽

Vol 6 (3) ◽

pp. 287-290 ◽

Cited By ~ 3

Author(s):

M. A. Climent ◽

Javier Palau ◽

Amparo Ruiz ◽

Virtudes Soriano ◽

Eduardo Aznar ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

Cancer Patients ◽

Peripheral Blood ◽

Peripheral Blood Stem Cell ◽

High Dose Chemotherapy ◽

High Dose ◽

Breast Cancer Patients ◽

Stem Cell Support ◽

94 P - Paclitaxel containing high-dose chemotherapy and autologous blood stem cell support for high risk primary breast cancer

European Journal of Cancer ◽

10.1016/0959-8049(96)84848-9 ◽

1996 ◽

Vol 32 ◽

pp. S19

Author(s):

H.T. Greinix ◽

W. Linkeach ◽

M. Seifert ◽

E. Kubista ◽

K. Czerwendka ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

High Risk ◽

Primary Breast Cancer ◽

Autologous Blood ◽

High Dose Chemotherapy ◽

Blood Stem Cell ◽

High Dose ◽

Stem Cell Support ◽

HER2 overexpression as a prognostic factor in metastatic breast cancer patients treated with high-dose chemotherapy and autologous stem cell support

Bone Marrow Transplantation ◽

10.1038/sj.bmt.1704619 ◽

2004 ◽

Vol 34 (5) ◽

pp. 413-417 ◽

Cited By ~ 7

Author(s):

V Guarneri ◽

C Bengala ◽

C Orlandini ◽

A Gennari ◽

S Donati ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose ◽

Her2 Overexpression ◽

Breast Cancer Patients ◽

Stem Cell Support ◽

386 High-dose chemotherapy with stem cell support in high-risk primary breast cancer. An analysis of the effect on overall survival the Danish experience from a comparison study

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(03)90418-6 ◽

2003 ◽

Vol 1 (5) ◽

pp. S118

Author(s):

T. Palshof ◽

S. Werner Hansen ◽

C. rose ◽

S. Møller ◽

P. Hokland ◽

...

Keyword(s):

Breast Cancer ◽

Overall Survival ◽

Stem Cell ◽

High Risk ◽

High Dose Chemotherapy ◽

High Dose ◽

Comparison Study ◽

Stem Cell Support ◽

Danish Experience ◽

Sequential Treatment Including High-Dose Chemotherapy With Peripheral Blood Stem Cell Support in Patients With High-Risk Stage II-III Breast Cancer

American Journal of Clinical Oncology ◽

10.1097/00000421-199810000-00022 ◽

1998 ◽

Vol 21 (5) ◽

pp. 523-531 ◽

Cited By ~ 12

Author(s):

Lee S. Schwartzberg ◽

Robert Birch ◽

William H. West ◽

Kurt W. Tauer ◽

Frederick Wittlin ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

High Risk ◽

Peripheral Blood ◽

Peripheral Blood Stem Cell ◽

High Dose Chemotherapy ◽

Stage Ii ◽

High Dose ◽

Stem Cell Support ◽

Adjuvant High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Support for High-Risk Primary Breast Cancer: Results from the Italian National Registry

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2013.12.569 ◽

2014 ◽

Vol 20 (4) ◽

pp. 501-506 ◽

Cited By ~ 5

Author(s):

Paolo Pedrazzoli ◽

Giovanni Martinelli ◽

Alessandro Massimo Gianni ◽

Gian Antonio Da Prada ◽

Alberto Ballestrero ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

High Risk ◽

Primary Breast Cancer ◽

High Dose Chemotherapy ◽

National Registry ◽

High Dose ◽

Hematopoietic Stem ◽

Stem Cell Support ◽

Expression of C-erbB-2/HER-2 in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous blood stem cell support

Bone Marrow Transplantation ◽

10.1038/sj.bmt.1701907 ◽

1999 ◽

Vol 24 (4) ◽

pp. 377-384 ◽

Cited By ~ 19

Author(s):

M Bewick ◽

T Chadderton ◽

M Conlon ◽

R Lafrenie ◽

D Morris ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

Autologous Blood ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose ◽

Stem Cell Support ◽

Her 2 ◽

High-dose chemotherapy (HDC) with autologous progenitor cell support (APCS) for breast cancer patients with high risk stage II–III, and stage IV with no evidence of disease (NED)

European Journal of Cancer ◽

10.1016/0959-8049(93)90989-s ◽

1993 ◽

Vol 29 ◽

pp. S71 ◽

Cited By ~ 1

Author(s):

S.M. Stemmer ◽

R.B. Jones ◽

E.J. Shpall ◽

S.I. Bearman ◽

S.E. Myers ◽

...

Keyword(s):

Breast Cancer ◽

High Risk ◽

Cancer Patients ◽

Progenitor Cell ◽

Stage Iv ◽

High Dose Chemotherapy ◽

Stage Ii ◽

High Dose ◽

Breast Cancer Patients ◽

Stem Cell Dose and Tumorbiologic Parameters as Prognostic Markers for Patients with Metastatic Breast Cancer Undergoing High-Dose Chemotherapy with Autologous Blood Stem Cell Support

Stem Cells ◽

10.1634/stemcells.20-1-32 ◽

2002 ◽

Vol 20 (1) ◽

pp. 32-40 ◽

Cited By ~ 7

Author(s):

Manfred Hensel ◽

Andreas Schneeweiss ◽

Hans-Peter Sinn ◽

Gerlinde Egerer ◽

Martin Kornacker ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

Prognostic Markers ◽

Autologous Blood ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose ◽

Stem Cell Support ◽

Expression of C-Erb B-2/Her-2 in Patients with Metastatic Breast Cancer Undergoing High-Dose Chemotherapy and Autologous Blood Stem Cell Support

Molecular Biology of Hematopoiesis 6 ◽

10.1007/978-1-4615-4797-6_12 ◽

1999 ◽

pp. 91-102

Author(s):

M. Bewick ◽

T. Chadderton ◽

M. Conlon ◽

R. Lafrenie ◽

Stefan Glück

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

Autologous Blood ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose ◽

Stem Cell Support ◽

Her 2 ◽